Apothecary Pharma recalls
2 federal recalls on file. We monitor every CPSC, FDA, USDA, and NHTSA notice for Apothecary Pharma and translate it into plain English — free weekly digest, optional same-day alerts.
- 2026-10-14FDA-DrugClass IIApothecary NAD+ Injection recalled for sterility concerns
Apothecary Pharma LLC is recalling one vial of Apothecary NAD+ Injection (200 mg/mL, 6 mL multi-dose vial, Lot #AP-202647) because the company cannot confirm the product meets sterility standards. A sterile injectable product that is not sterile poses a risk of infection if injected.
- 2026-10-14FDA-DrugClass IIApothecary Pharma Tirzepatide Injection recalled for sterility concerns
Apothecary Pharma LLC is recalling Tirzepatide Injection 18mg/mL vials because the manufacturer cannot guarantee the product is sterile. The affected vials were distributed nationwide. No infections or injuries have been reported so far.
Get the week's recalls, including Apothecary Pharma
Free weekly digest — every federal recall affecting your household, Apothecary Pharma included when it comes up. Track Apothecary Pharma specifically with Always-on.